The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Organoids Global Market Report 2024, the organoids market is expected to show significant growth in the forecast period.

The organoids market has experienced exponential growth, driven by advancements in biomedical research, drug discovery, disease modeling, and personalized medicine. Valued at $1.42 billion in 2023, the market is projected to reach $1.78 billion in 2024, with a compound annual growth rate (CAGR) of 25.1%. This growth trajectory is expected to continue, reaching $4.38 billion by 2028, with a CAGR of 25.2%.

Increasing Clinical Trials for Drug Development Fuel Market Growth
The organoid market is expected to be propelled by the increasing number of clinical trials for drug development. Organoids are utilized in these trials to model diseases, test drug responses, and enhance personalized medicine approaches. The significant rise in registered clinical trials globally underscores the growing importance of organoids in advancing drug development and improving patient care.

View More On The Organoids Market Report 2024 – https://www.thebusinessresearchcompany.com/report/organoids-global-market-report

Technological Advancements Drive Market Trends
Technological advancements are a key trend in the organoid market, with major companies launching new organoid technologies to stay competitive. For instance, MIMETAS introduced a new type of adult stem cell (ASC)-derived tubular organoids for mechanistic toxicology and drug-induced organ injury, showcasing innovative technology in 3D biology solutions.

Molecular Devices Acquires Cellesce Ltd. to Strengthen Portfolio
In a strategic move, Molecular Devices LLC acquired Cellesce Ltd. to enhance its 3D biology solutions portfolio. This acquisition will provide Molecular Devices LLC with human-derived cell or organoid lines from Cellesce Ltd., bolstering its position as an innovator in the field of organoid technology.

The Future of Organoids: Advancing Research and Development
The organoids market is segmented by product, source, application, and end-user, reflecting the diverse applications and growing demand for organoid technologies. With North America leading the market in 2023 and Asia-Pacific expected to be the fastest-growing region, the future of organoids holds immense promise in revolutionizing biomedical research and drug discovery.

Request A Sample Of The Global Organoids Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10787&type=smp